Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 63 citing articles:

Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy
Mingqi Liu, Yang Feng, Yougong Lu, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 30
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 23
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Autophagosomes coated in situ with nanodots act as personalized cancer vaccines
Weiqiang Huang, Wei You, Ya-Qi Zhu, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
Boosting Theranostic Performance of AIEgens Using Nanocatalyzer for Robust Cancer Immunotherapy
Yue Li, Zekun Du, Yuan Zhang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 23
Closed Access | Times Cited: 14
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 11
Uplifting Antitumor Immunotherapy with Lymph‐Node‐Targeted and Ratio‐Controlled Codelivery of Tumor Cell Lysate and Adjuvant
Guanhong Cui, Yinping Sun, Liping Qu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 17
Closed Access | Times Cited: 10
PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapy
Liang Yin, Shufang Ning, Mekhrdod S. Kurboniyon, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access | Times Cited: 1
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Laser‐Activatable In Situ Vaccine Enhances Cancer‐Immunity Cycle
Zhenyu Wang, Tingting You, Qianyi Su, et al.
Advanced Materials (2023) Vol. 35, Iss. 52
Closed Access | Times Cited: 18
In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases
Yuan Li, Fan Tong, Yufan Wang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4102-4117
Open Access | Times Cited: 7
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 6
Engineering platforms for localized long-acting immune modulation
Corrine Ying Xuan Chua, Dixita Viswanath, David P. Huston, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 153, Iss. 3, pp. 572-575
Open Access | Times Cited: 5
Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside
Hadeel Ahmed Kenoosh, Harikumar Pallathadka, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 5
Macrophage lysate-derived cytokine network combined with silk fibroin hydrogel promotes diabetic vascularized bone regeneration
Muxin Yue, Yong-sheng Zhou, Zheng Li
Chemical Engineering Journal (2024) Vol. 490, pp. 151892-151892
Open Access | Times Cited: 5
Cancer biotherapy: review and prospect
Qi Liu, Hu Ma
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
The anti-tumor effect of the IFNγ/Fas chimera expressed on CT26 tumor cells
Seo Yeon Jeon, Hwachul Shin, Hayyoung Lee, et al.
Animal Cells and Systems (2025) Vol. 29, Iss. 1, pp. 46-56
Open Access
Autologous Nanovaccine Induces Immunogenic Domino Effect to Prevent Postoperative Recurrence of Orthotopic Glioblastoma
Jinghong Yang, Ke Zhang, Guangliang Zhang, et al.
Advanced Functional Materials (2025)
Closed Access
Whole‐Component Antigen Nanovaccines Combined With aTIGIT for Enhanced Innate and Adaptive Anti‐tumor Immunity
Weitao Wang, Haitao Wu, Xuan Zhang, et al.
Small (2025)
Closed Access
Functionalized Poly(ethylene Glycol) Diacrylate Scaffolds for In Situ Immunomodulation of Dendritic Cells Targeting Melanoma Tumor
Neha Dalal, Hemavathi Dhandapani, Arvind Ingle, et al.
ACS Biomaterials Science & Engineering (2025)
Closed Access
Personalized tumor vaccines based on carrier-free double-adjuvant nanoparticles and tumor-associated antigens for enhancing immune responses
Hanyong Wang, Wei Zhang, Chenlu Huang, et al.
Chinese Chemical Letters (2025), pp. 111092-111092
Closed Access
Galloylated Toll-Like Receptor 7/8 Agonist Nanovaccine for Enhanced Tumor Antigen Delivery in Personalized Immunotherapy
Mengyao Ma, Ximu Li, Mingyuan Zhong, et al.
ACS Nano (2025)
Closed Access
Neoantigen vaccines: advancing personalized cancer immunotherapy
Alaa A. A. Aljabali, Yassmen Hamzat, Alaa Alqudah, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
Exosome‐Based Vaccines: Pioneering New Frontiers in Combating Infectious Diseases and Cancer
Xuejun Wang, Aixue Li, Ailing Wang, et al.
Small Methods (2025)
Closed Access
Page 1 - Next Page

Scroll to top